go back

Tocilizumab Infusion for COVID-19, First Dose

Vermont rates for HCPCS M0249

Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with COVID-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, first dose

Rates data updated July 2026.

How much does Tocilizumab Infusion for COVID-19, First Dose cost?

$447

Typical physician fee. In Vermont, July 2026.

Insurers have agreed to pay about $447 for this service. Most negotiated rates run $447 to $447.

These are rates insurers have negotiated with providers, not the amount a patient is billed. What you owe depends on your plan's deductible and coinsurance. Based on rates published by 3 insurance carriers under federal price transparency rules.

How much rates vary

Professionalmedian $447 · 10th to 90th $447 to $661
$500.0$1.0Kprofessional $447

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$446.68
Median
$446.68
Typical High
$446.68
Cigna
Setting
Professional
Modifier
Global
Typical Low
$398.11
Median
$398.11
Typical High
$398.11
United
Setting
Professional
Modifier
Global
Typical Low
$602.56
Median
$691.83
Typical High
$954.99

Where Vermont sits

The same service costs 1.7 times more in North Dakota than in Alabama. Every bar is a state, most expensive first. Pick one to see its carriers and full range.

Vermont $447 · 20th of 51
ND $759AL $447

Median negotiated rate in each state, from every insurer that publishes one. States where no insurer publishes a rate for this service are not shown.